
Cradle Healthcare, a startup founded by Thiel fellow Laura Deming, has raised $48 million to advance reversible cryopreservation technology. The company focuses on reanimating frozen body tissue, aiming to make cryonics a viable option for humans. Deming, known for her work in longevity, emphasizes the importance of not just freezing but also reviving tissues with full functionality. In her first interview about the startup, Deming highlighted Cradle Healthcare's achievement of recovered neuronal activity from frozen rat brains, a significant milestone in the field. The team, praised for matching the ambition of their groundbreaking idea, is one of the few capable of making reversible cryopreservation work.









Deming says other companies tend to place too much emphasis on freezing and not enough on reviving. “We’re working on reversible cryo, which means building procedures that can cryopreserve and rewarm with function,” Deming, 30, says in her first interview about the startup.🧊 https://t.co/xZPdBJw8fd
oh hell yeah! we are so close to immortality i can taste it. we have been able to cryopreserve eggs and sperm for a while now, but resuming electrical activity in neurons was the holy grail and the madlady did it! every day a step forward https://t.co/mLYXK2X9mF https://t.co/c059X5LuuY
Thiel fellow @LauraDeming (who has up to now been running a longevity fund) just raised $48M to solve *reversible* cryopreservation 👀🧊 See screenshot, where they claim recovered neuronal activity from frozen rat brains https://t.co/9P3ivLg1If